Wagner Wealth Management (South Carolina)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-200
Closed -$25K – 350
2022
Q3
$25K Hold
200
– – 0.02% 280
2022
Q2
$27K Buy
+200
New +$27.3K 0.02% 279
2022
Q1
– Sell
-200
Closed -$35K – 319
2021
Q4
$35K Buy
+200
New +$30.4K 0.03% 306
2018
Q3
$70K Hold
650
– – 0.05% 227
2018
Q2
$71K Hold
650
– – 0.05% 207
2018
Q1
$65K Sell
650
-400
-38% -$41K 0.05% 199
2017
Q4
$106K Buy
+1,050
New +$99.5K 0.08% 170

Other funds holding DGX

Wagner Wealth Management (South Carolina)'s DGX Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 200 shares — an estimated $25K sold.

Wagner Wealth Management (South Carolina) first reported a position in DGX in Q4 2017 and held it in 7 quarters. The position peaked at $106K in Q4 2017. 878 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 200 Quest Diagnostics shares in Q4 2022, an estimated $25K.
  • Wagner Wealth Management (South Carolina) first reported a position in Quest Diagnostics in Q4 2017 and held it in 7 quarters.
  • Wagner Wealth Management (South Carolina)'s Quest Diagnostics position peaked at $106K in Q4 2017.
  • 878 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.